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COMMENTARY
Quantitative analyses of adiposity dynamics in zebrafish
Loes M.H. Elemans , Iris Pruñonosa Cervera, Susanna E. Riley, Rebecca Wafer, Rosalyn Fong, Panna Tandon ,
and James E.N. Minchin
Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK
ABSTRACT
Adipose tissues often exhibit subtle, quantitative differences between individuals, leading to a
graded series of adiposity phenotypes at the population level. Robust, quantitative analyses are
vital for studying these differences. In this Commentary we highlight two articles from our lab that
employ sensitive new methods in zebrafish capable of delineating complex and quantitative
adiposity phenotypes. In the first article, we utilized in vivo imaging to systematically quantify
zebrafish adipose tissues. We identified 34 regionally distinct zebrafish adipose tissues and
developed statistical models to predict the size and variance of each adipose tissue over the
course of zebrafish growth. We then employed these models to identify effects of strain and diet
on adipose tissue growth. In the second article, we employed deep phenotyping to study
complex disease-related adiposity traits. Using this methodology, we identified that adipose
tissues have unique capacities to re-deposit lipid following food restriction and re-feeding.
These distinct re-deposition potentials led to widespread fat distribution changes following re-
feeding. We discuss how these novel findings may provide relevance to health conditions such as
anorexia nervosa. Together, the strategies described in these two articles can be used as unbiased
and quantitative methods to uncover new relationships between genotype, diet and adiposity.
ARTICLE HISTORY
Received 22 February 2019
Revised 17 July 2019
Accepted 22 July 2019
KEYWORDS
zebrafish; adipose tissue;
animal models
Commentary
Adiposity is a quantitative trait and a key
determinant of disease risk
The worldwide prevalence of obesity is increasing dra-
matically, and has resulted in a concomitant increase in
obesity-associated diseases such as type 2 diabetes and
cardiovascular disease [1,2]. Obesity is characterised by
excessive accumulation of lipid within adipose tissues
(AT) and subsequent AT dysfunction [3,4]. ATs are
specialized lipid-accumulating structures that primarily
come in two distinct types: white and brown [5]. White
adipose tissues (WAT) have a range of diverse func-
tions; however, a primary role is to regulate systemic
energy homeostasis by releasing lipid into, or seques-
tering lipid from the circulation [5]. Brown adipose
tissue (BAT) is thermogenic and utilises stored lipid
to generate heat [6]. Obesity is highly heritable suggest-
ing a large genetic component [7], and, at a population
level, adiposity levels (composed primarily of WAT) are
highly variable and form a continually graded series
from one adiposity extreme to the other [8]. Genome-
wide association studies (GWAS) have begun to iden-
tify the polygenic genetic architecture underlying adip-
osity [9–11]. However, as adiposity is a complex,
quantitative trait, individual underlying mechanisms
may only account for relatively small, subtle effects
[12,13]. Traditional model systems to study adiposity
often suffer from low statistical power and an inability
to detect small differences [14]. Therefore, new model
systems are needed that facilitate quantitative analysis
of adiposity with large sample sizes.
The regional distribution of adipose tissues is
a strong predictor of disease
In addition to absolute AT levels, the regional distribution
of ATs is also a strong predictor of disease susceptibility.
ATs are distributed throughout the body [5,15,16]. In
humans, ATs are primarily found in subcutaneous loca-
tions or within the abdominal cavity [5,17], although
increasing functional importance is being established for
bone marrow AT [18]. The regional location of AT influ-
ences disease risk. For example, accumulation and dys-
function of WAT around the abdomen, primarily
surrounding visceral organs (VAT), is strongly associated
with metabolic disease risk [19,20]. Conversely, lower-
body gluteofemoral subcutaneous WAT (SAT) and
abdominal SAT have been shown to protect against meta-
bolic dysfunction [20–30]. Therefore, the regional
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distribution of WAT influences disease risk, and accord-
ingly, proportionality between WATs (e.g., the ratio of
upper to lower body WAT or the ratio of VAT to SAT)
are strong predictors for the future development of meta-
bolic disease [31,32]. It would be highly advantageous to
develop a model system with the ability to quantify all
ATs in an individual and ascertain in an unbiasedmanner
how inter-AT relationships change and influence disease
susceptibility [20]. This need is typified by proportionality
changes between distinct WATs having unique and dis-
tinct influences on disease [33,34]. Owing to these inter-
AT relationships, it is important to assess adipose attri-
butes (e.g., size, shape, location etc) relative to other ATs.
In more traditional model systems used to study adipos-
ity, it is typically difficult to image whole-animal adiposity
at reasonable resolution and with large enough sample
sizes to detect small effects. Therefore, newmodel systems
are needed to study inter-AT relationships and
interactions.
Zebrafish is an innovative model system to assess
quantitative traits such as adiposity levels and
adipose distribution
Zebrafish provide a tractable, evolutionarily conserved
and optically transparent model system for whole-
animal and quantitative measurement of adiposity.
Zebrafish AT is morphologically homologous to mammal
WAT [35–37]. Zebrafish AT expresses specific markers of
mammalian WAT, including pparg, cebpa and fabp11a
(the zebrafish ortholog of mammalian FABP4) [35,37–
39]. Further, zebrafish AT appears to function in an
equivalent manner to mammalian WAT; mobilizing
lipid in response to food restriction and accumulating
increased lipid in response to caloric overload
[37,40,41]. As zebrafish do not regulate their body tem-
perature, current dogma suggests that zebrafish do not
possess thermogenic BAT [16]; however, this has not been
fully assessed. Intriguingly, a conserved uncoupling pro-
tein 1 (ucp1) gene is present in ectothermic teleosts
(including zebrafish) [42,43], and warm acclimated liver
mitochondria from carp exhibit a GDP-sensitive and fatty
acid-inducible proton leak reminiscent of Ucp1-mediated
uncoupling in mammalian mitochondria [44]. It is com-
pletely unknown whether zebrafish possess beige adipo-
cytes, which reflects the nascent state of AT research in
zebrafish. Mammalian WAT secretes an array of hor-
mones (adipokines) including Adiponectin, Leptin,
Resistin, TNFa, IL6, and aP2 [45]. The presence and role
of adipokines in zebrafish AT is largely unstudied. adipo-
nectin is expressed by zebrafish adipocytes; however,
a functional role in zebrafish is unknown [35]. Zebrafish
possess two leptin genes [46], and a function for Leptin as
an ‘adipostat’ does not appear to be conserved in zebrafish
[47,48]. Thus, although some aspects of WAT biology are
understudied in zebrafish, it is clear that WAT is highly
conserved in zebrafish and fulfils similar functions to
mammalian WAT. In addition to biomedical impact,
modellingWAT biology in zebrafishmay provide insights
relevant to the aquaculture industry [49]. To summarize,
modelling adiposity traits in zebrafish is likely to provide
information relevant concerning mammalian WAT with
the potential to lead to new insights for therapeutic
intervention.
In vivo imaging with fluorescent lipophillic dyes
can be used to quantify adipose tissues in zebrafish
ATs are highly dynamic organs, which are unique to bony
vertebrates [16]. In mammals WAT is first formed during
embryonic development [16]. In both mice and humans,
SAT development is first detected in the embryo, while
VAT develops postnatally [50]. In zebrafish, the develop-
ment of AT differs with VAT first forming in the post-
embryonic fish at around 14 dpf (days post fertilisation),
before SAT appears later [40,51] (Figure 1). Once AT has
been deposited in zebrafish, it expands to form a vast array
of adipose depots at anatomically distinct locations [40,51]
(Figure 1a). Quantification of total AT reveals how exten-
sively adipose expands in zebrafish (Figure 1b). To quantify
AT distribution, we recently published an article that char-
acterised 34 adipose depots present in zebrafish and
described AT growth characteristics [40,51]. This study
provides a standard classification system and nomenclature
of zebrafish AT to support the use of this animal model in
AT research (Figure 1a). Specifically, the classification sys-
tem was adapted from a previous system used in human
AT classification [17]. In our study, fluorescent lipophilic
dyes (FLDs) and whole-animal in vivo imaging were used
to identify, quantify and classify AT depots in zebrafish,
according to their anatomical location [40,51]. Extensive
information on use of FLDs can be found in Minchin and
Rawls [40,51]. Use of FLDs and imaging on a stereoscope
allows rapid imaging and large sample sizes. However, for
more detailed (higher resolution) analyses like confocal
imager, smaller sample sizes are used. We verified that
FLD-labelled AT is an accurate proxy for triacylglyceride
(TAG) content [41,52] and, as proof-of-principle, FLD+
areas of three distinct ATs (PVAT, AVAT and CFRSAT)
were measured and then dissected and quantified for TAG
content by a fluorimetric assay [51]. We found that FLD+
area was an accurate predictor for TAG mass for each AT
(R2 = 0.78, 0.87 and 0.82; all P < 0.0001), which supported
the method of area measurements of individual ATs as an
accurate estimator of lipid content. These methods are
relatively fast to undertake and large sample sizes were
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achievable [51,53]. Therefore, FLDs allow the large-scale
collection of quantitative adiposity data.
Generation of a classification system to study
zebrafish adipose tissues
To facilitate the study of inter-AT relationships, we
used FLD-based imaging to generate a comprehensive
anatomical classification system for zebrafish ATs. We
found that total AT in zebrafish was divided into inter-
nal AT (IAT) and subcutaneous ATs (SAT) (Figure 1a)
[40,51]. IAT can be associated with internal visceral
organs (visceral IAT, VAT) or not (non-visceral IAT,
NVAT) and can be divided in pancreatic VAT (PVAT),
abdominal VAT (AVAT), renal VAT (RVAT) and car-
diac VAT (CVAT) depending on the associated organ
(Figure 1a). PVAT is the first adipose tissue to form in
the zebrafish, being deposited at around 4.2 mm in fish
length (called standard length; SL). After the initiation
of PVAT development, it undergoes uninhibited
growth until RVAT is first detected. After the forma-
tion of RVAT, at ~8 mm SL, IAT expansion slowed
(Figure 1d & e). In contrast to this growth profile, SAT
did not appear until ~6 mm SL and was then observed
to undergo uninhibited expansion throughout the
remainder of the data set (Figure 1d & e) [51]. SAT is
located between the dermis and the aponeuroses and
fasciae of the muscles and can be associated with the
trunk (truncal SAT, TSAT), head (cranial SAT, CSAT)
and fins (appendicular SAT, APPSAT). SAT can be
divided into lateral SAT (LSAT) running laterally
along the trunk, dorsal sat (DSAT) in the dorsal-most
trunk and ventral SAT (VSAT) between the anal and
caudal fins. CSAT Is the first SAT to appear in zebra-
fish and can be found in the operculum (OPC), eye
(ocular CSAT, OCU) and hyoid apparatus (HYD).
Figure 1. Quantitative analysis of adiposity in zebrafish. a. Tree documenting the 34 regionally distinct adipose tissues and their
anatomical relatedness. See Minchin et al., (2017)[51] for further details. Total adipose tissue is first divided into internal (IAT) and
subcutaneous (SAT) adipose. Schematic of zebrafish details anatomic location of each adipose tissue (colour coded). b. Quantification
of the increase in total adipose area as zebrafish grow. The nine categories (PVAT, AVAT, HYD, OCU, LSAT, cPOS, AFCSAT, CFRSAT and
aPECSAT) represent post-embryonic stages of zebrafish development as detailed in Minchin et al., (2017) [51]. c. Representation of
the standardised standard lengths at which established post-embryonic (PE) stages have been identified, together with the adipose
tissue (AT) stages identified in Minchin et al., (2017) [51]. d. Graph showing body fat % relative to standard length. Note the change
in the slope of the line from ~8 mm standard length (lower graph). Upper graphs show datapoints from <8 mm (upper left graph) or
>8 mm (upper right graph). Note the decrease in allometric growth rate (k) in fish >8 mm. These data show that the rate of body fat
accumulation slows after 8 mm SL coincident with the appearance and diversification of SAT. e. Graph showing the temporal
dynamics of VAT and SAT accumulation in zebrafish. Note, prior to 8 mm SL VAT exhibits substantial growth, which plateaus at
~8 mm SL coincident with the appearance of SAT.
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APPSAT can be divided in pelvic fin SAT (PELSAT),
anal fin ray SAT (AFRSAT), dorsal fin ray (DFRSAT),
anal fin cluster SAT (AFCSAT), caudal fin ray SAT
(CFRSAT) and pectoral fin SAT (PECSAT) (Figure
1a). The identification of these ATs, together with pre-
dictions for when they appear, allowed us to define new
AT-related post-embryonic staging criteria (Figure 1c).
Taken together, this classification system will facilitate
analysis of inter-AT relationships and their response to
dietary and genetic manipulation.
Quantitative models help predict the expected sizes
of zebrafish adipose tissues
In addition to a classification system, we also generated
statistical models to predict AT size and variance.
Quantification of the size of each AT along with the devel-
opmental stage at which they appear allowed us to apply
logistical regressionmodels that accurately predict the time
of AT appearance and size throughout development [51].
These statistical models will facilitate analysis of potentially
small deviations following genetic or dietary manipula-
tions. We found that new ATs appeared throughout devel-
opment and gave a steady increase in total AT area (Figure
1b). However, growth within each AT occurred at different
rates and ATs appeared at different developmental mile-
stones (Figure 1b) [51]. Apart from in urohyoid AT
(UHD), SL could predict over 50% of the size variance in
all depots (mean R2 = 0.84), suggesting that the size of ATs
is a function of SL [51]. Age was the best predictor of UHD
size (R2 = 0.44) with other measures of zebrafish size failing
to reach this level of prediction [51]. SL had a reduced
predictive ability (mean R2 = 0.51) in other ventral ATs
(e.g. hyoid apparatus adipose), suggesting possible experi-
mental error in their measurement [51]. Tracking of body
fat % reveals that prior to reaching 8 mm SL, zebrafish
undergo a rapid accumulation of body fat primarily in
VAT (Figure 1d). This is supported by tracking the times
of AT development which showed that VAT appears first
and rapidly expands before slowing as SAT appears and
diversifies (Figure 1e). Therefore, a model can be proposed
whereby zebrafish initially deposit lipid in VAT during
rapid increases in body fat (Figure 1d & E). However,
from ~8 mm SL, zebrafish slow the rate of body fat accu-
mulation and begin storing lipid in diverse SAT sites
(Figure 1d & e). These interesting dynamics suggest that
VAT may be beneficial for post-embryonic development
and survival, and further suggest that ~8mm SL is a critical
size for the zebrafish to reach before accumulation of body
fat % slows. Altogether, the predictive power of these
statistical models will facilitate robust analyses of quantita-
tive adiposity traits in zebrafish.
Applying quantitative in vivo imaging to analyse
diet and strain effects on adiposity in zebrafish
Following the generation of a classification system and
statistical models to study zebrafish adiposity, as
a proof-of-principle, we also examined the effects of
diet and genotype. A high-fat diet (HFD) supplement
was introduced to increase the adiposity of our speci-
mens and to evaluate the utility of the AT classifica-
tion system [51]. The supplement, 5% chicken egg
yolk (CEY), was provided to 27 dpf zebrafish in addi-
tion to the standard feed during 14 days in daily
incubations of 2 hours. After the supplementation,
total AT area was increased in the HFD-exposed spe-
cimens compared to their counterparts without an
increase in SL [51]. Furthermore, by applying our
classification system and predictive models we identi-
fied that VAT enlarged to a greater degree following
HFD than SAT, suggesting that ATs in different
regions can have different responses to HFD in zebra-
fish [51]. The abovementioned analyses were per-
formed in the Ekkwill (EKW) zebrafish strain. To
determine whether these dynamics were comparable
across genetic backgrounds, ATs from the WIK zebra-
fish strain were also quantified [51]. There were no
differences in AT types, configuration, and timing of
AT appearance between the two strains [51].
However, as seen in previous work by McMenamin
et al [54], WIKs had a smaller SL at a comparable
EKW developmental stage [51]. In agreement with
this, WIKs at the PR developmental stage
(~7.4–9.1mm SL) had smaller AT sizes [51].
However, by the pCVAT developmental stage, WIKs
had reduced IAT and increased SAT relative to EKWs
[51]. Intriguingly, although fat distribution was altered
between the strains, no difference was observed in
total AT [51]. Taken together, these experiments
demonstrate the utility of the classification system
and predictive models to discern complex and subtle
AT distribution differences in zebrafish and in
response to diet manipulation and genetic differences.
Deep phenotyping and phenomics to study
complex, quantitative traits
Deep phenotyping, or phenomics, offers an effective
strategy to comprehensively analyse quantitative adip-
osity traits. The phenome describes a comprehensive
set of biochemical or physical traits which belong to
a given organism [55]. Deep phenotyping refers to the
measurement of phenomes as they change in response
to genetic mutation and environmental influences
[56]. Deep phenotyping has been successfully used in
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zebrafish to identify skeletal deformations [57,58].
However, deep phenotyping has so far not been
applied to complex adiposity phenotypes. Current
phenotyping of organisms is typically limited to the
focus of the individual scientist, while advocates of
phenomics argue that phenotypic data should instead
be collected at multiple levels of granularity, from
behavioural phenotypes to cell specific changes
[59,60]. Phenomic level data is thought to be necessary
to understand how genetic variants affect phenotypes
and to provide raw data to decipher the causes of
complex disease [55]. Furthermore, phenomics allow
the determination of links between genotypes, envir-
onmental factors and phenotypes resulting in the for-
mation of the genome-phenome map, which is related
to the multiple ways genotypic information influences
the phenotype of an organism [55]. Another aim of
phenomics is to understand the genetic regulation of
complex traits [61]. GWAS have identified many
genetic associations with disease, but these associa-
tions do not account for all of the observed phenoty-
pic variance [62]. One example of this is human
height, where nearly 200 validation loci explain only
10% of the genetic variation. The ‘missing heritability’
can be associated with thousands of single nucleotide
polymorphisms (SNPs), which are either very rare or
have very small effects at the population level [63]. It
has been suggested that traditional disease risk factors
such as weight and blood chemistry are more powerful
predictors of disease than SNP associations [64,65].
Therefore, increased levels of phenotypic data pro-
vided by deep phenotyping may be useful in disease
prediction, particularly with subtle and quantitative
adiposity traits.
Applying deep phenotyping to study quantitative
adiposity traits in zebrafish
There have been multiple efforts to map the phe-
nome of various model organisms, and a zebrafish
phenome project was proposed in 2010 [60]. We
recently published an article which applied deep phe-
notyping techniques to assess adiposity changes in
zebrafish [53]. Our goal was to use the quantitative
methods of zebrafish AT identification described pre-
viously [40,51] and couple this to deep phenotyping
to analyse complex responses of adipose tissues to
genetic and environmental perturbations [53]. After
quantification of all ATs in the zebrafish, we rea-
soned that collecting large amounts of quantitative
adiposity data could be used to classify individuals
based on their adiposity profiles and could then be
used to identify subtle, quantitative adiposity
phenotypes. Existing data was utilized to generate
post-embryonic stage-specific phenotypic profiles
that capture adiposity information (adiposity profiles)
[53]. From 456 zebrafish, 67 traits were quantified in
each fish, including AT area measurements, measures
of body size (SL and body area), composite AT
groupings (total AT, VAT and SAT) and AT propor-
tionality assessments (VAT:SAT ratios). Correlations
were computed between each trait and assessed to
determine how adiposity relationships and patterns
change in fish of distinct stages [53]. As expected,
considerable differences in adiposity profiles at dis-
tinct stages were observed. For example, PVAT was
initially positively correlated with SL (stage PB),
before becoming progressively more inversely corre-
lated with SL in larger fish (stage SA) [53]. Therefore,
we reason that adiposity profiles capture dynamic
changes in adiposity patterns at distinct developmen-
tal stages and can thus be useful indicators of ‘nor-
mal’ adiposity levels and variation.
Multivariate statistics to identify small,
quantitative adipose phenotypes in zebrafish
Linear discriminant analysis (LDA) is a data dimen-
sionality reduction technique used for pattern classi-
fication and machine learning applications. LDA is
used to maximize the variance within data and sepa-
rate the data into classes based on the variance. LDA
was used to classify individual fish according to
expected adiposity traits. LDA assigned 87.5% of the
wild-type fish into correct stages based on adiposity
profiles [53]. Across multiple independent clutches,
LDA resulted in an average classification rate of
84.8 ± 2.4% (mean ± SE). As proof-of-concept, zeb-
rafish growth hormone (gh) mutants were used to
determine if LDA can be used to detect adiposity
phenotypes, as these mutants show increased adipos-
ity relative to size-matched wild-type siblings [66].
LDA correctly identified 60% of cases based on adip-
osity profiles in the gh mutant clutch, and 36% in
mixed wild-type and mutant clutches. In conclusion,
we found LDA could be used to identify phenotypic
adiposity traits based on adiposity profiles. To further
apply LDA methodology, a small-scale ‘shelf’ screen
of mutants was used to help identify novel zebrafish
adipose mutants [53]. Of the eight mutant lines,
nrp2b robustly presented mutant identification rates
higher than expected from wild-type zebrafish, sug-
gesting that nrp2b mutation may influence adiposity
in zebrafish. Intriguingly, in a subsequent F0 screen
for genes implicated in hypothalamic obesity, we also
identified nrp2b as an important regulator of
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adiposity [67]. In the latter study we identified wide-
spread increases in adiposity in nrp2b mutants [67].
However, the sa18942 allele exhibited specific
decreases in PVAT [53]. It will be important to
reconcile these apparent phenotypic differences by
assessing wider aspects of adiposity in the sa18942
mutants, together with analysis of PVAT in F0
mutants. Further, the strategy for mutating nrp2b
differed in these two studies – the sa18942 mutation
is a single base-pair change in an essential splice site,
whereas in the latter study we utilised multiplex
CRISPR to generate larger deletions towards the
translational start [53,67].
Deep phenotyping to identify the effect of diet on
zebrafish adipose tissues
In Minchin et al. [53],,LDA was applied to identify
diet-induced changes in adiposity (Figure 2). Zebrafish
were subjected to prolonged food restriction followed
by re-feeding until total adiposity levels were comple-
tely replenished (Figure 2). During the course of diet
manipulation, the Nile Red stained zebrafish showed
that AT-localised lipid was fully mobilised during food
restriction as shown by the lack of Nile Red+ lipid
within adipose tissue (Figure 2). Principal component
analysis (PCA) was used to identify whether adiposity
trait dynamics were different during food restriction
Figure 2. Food restriction and re-feeding in zebrafish. Data taken and re-plotted from Minchin et al. [53]. A. Experimental design
showing food restriction (starvation) and re-feeding over the course of 22 days. B. Schematic showing the breakdown of
experimental groups at each stage of the experiment. EKE cohort represents size-matched wild-type fish from a previously described
cohort (Minchin & Rawls, 2017). C. Growth trajectories of continuously fed (green) and starved and re-fed siblings (red). Lines
represent the growth trajectories of individual fish. Circles represent the mean standard length and coloured bars represent the
standard deviation of standard lengths. As can be seen, the starved and re-fed animals slow their growth during food restriction
(stage 2). D. Analysis of total AT in the starved and re-fed (red), continuously fed (green) and size-matched EKW control zebrafish
(blue). As before, lines represent the growth trajectories of individual fish. Circles represent the mean standard length and coloured
bars represent the standard deviation of standard lengths. Note the loss of total AT in starved and re-fed animals during stage 2,
followed by re-deposition during stage 3 (re-feeding). Note also, that starved and re-fed animals ‘catch-up’ to size-matched wild-
type control fish (blue). E,F. Analysis showing the equivalency in size in animals used for comparative analysis.
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and re-feeding, and strikingly, PCA suggested that food
restriction and re-feeding elicits changes in AT distri-
bution even after complete recovery of total AT levels.
Furthermore, IATs had a more limited capacity to
replenish lipid when compared to SAT in size-
matched ‘continuously-fed’ animals. The average IAT
recovery was ~80%, whereas SAT recovery was ~160%,
leading to a reduced IAT:SAT ratio compared to size-
matched ‘continuously fed’ control fish. Taken
together, food restriction and re-feeding leads to altered
fat distribution even after full replenishment of AT
levels, which is caused by a general failure of internal
ATs to replenish lipid levels leading to differences in
body fat distribution.
Anorexia nervosa – medical relevance of changes in
body fat distribution following food restriction and
recovery
Our findings that food restriction and re-feeding can
alter body fat distribution is of potential medical
importance – is there evidence for fat distribution dif-
ferences following dietary intervention in humans?
Anorexia nervosa is a health problem associated with
reduced food intake and low body fat [68]. Recovery of
body fat levels in anorexic patients is a key treatment
strategy [68]. Owing to such an important medical
condition, an extensive literature is present on body
fat distribution both before and after weight restoration
in anorexia nervosa. Intriguingly, studies of adolescent
or adult females with anorexia nervosa identified dif-
ferent effects on fat distribution – adolescents had
greater reductions in visceral adipose, whereas adults
had greater reductions in subcutaneous and adipose at
extremities [69–75]. Strikingly, weight restoration in
adults with anorexia nervosa led to a 212% increase in
subcutaneous fat and only a 117% increase in visceral
fat [75]. These data show that body fat distribution
changes in anorexia nervosa and following weight
recovery is related to development and suggests that
zebrafish may be a useful model system for assessing fat
distribution changes in anorexia nervosa.
Conclusions
To conclude, deep phenotyping offers considerable
potential for the identification of parameters that
signify health and disease. Particularly, deep pheno-
typing is important for adiposity traits which often
exhibit complex and continuous phenotypes which
are often inadequately assessed by qualitative meth-
ods. Quantitative methodology is essential to evaluate
complex morphological and functional phenotypic
changes, particularly for understanding and interpret-
ing health and disease states. In zebrafish, we identi-
fied a striking phenotype whereby IATs do not fully
replenish lipid following re-feeding, compared to
total AT levels of normally fed individuals.
Furthermore, SATs have a greater capacity to re-
deposit lipid compared to VATs and, after re-
feeding, zebrafish display decreased IAT:SAT ratios.
Accumulation of SAT is associated with reduced risk
of metabolic disease in humans [30] and zebrafish
[76,77], raising the possibility that the increased
SAT accumulation induced by long-term food restric-
tion and refeeding may have favourable health effects.
Deep phenotyping and phenomics can be used as
a new method to assess adiposity profiles in zebra-
fish, which will be useful to identify new genetic and
environmental factors governing AT development
and physiology.
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